reviewPharmaceuticalsJan 15, 2025GOLD OA

Targeting Cytokine-Mediated Inflammation in Brain Disorders: Developing New Treatment Strategies

University of Eastern Finland · Indian Council of Medical Research · +7 more institutions

PubMed
Indexed incrossrefdoajpubmed

Abstract

Cytokine-mediated inflammation is increasingly recognized for playing a vital role in the pathophysiology of a wide range of brain disorders, including neurodegenerative, psychiatric, and neurodevelopmental problems. Pro-inflammatory cytokines such as interleukin-1 (IL-1), tumor necrosis factor-alpha (TNF-α), and interleukin-6 (IL-6) cause neuroinflammation, alter brain function, and accelerate disease development. Despite progress in understanding these pathways, effective medicines targeting brain inflammation are still limited. Traditional anti-inflammatory and immunomodulatory drugs are effective in peripheral inflammatory illnesses. Still, they face substantial hurdles when applied to the central nervous…

No related works found for this paper.

Funding